Data in the biological, chemical, and clinical domains are accumulating at ever-increasing
rates and have the potential to accelerate and inform drug development in new ways …

Data in the biological, chemical, and clinical domains are accumulating at ever‐increasing
rates and have the potential to accelerate and inform drug development in new ways …

Drug repurposing has become an important branch of drug discovery. Several
computational approaches that help to uncover new repurposing opportunities and aid the …

Biomedical discovery has been reshaped upon the exploding digitization of data which can
be retrieved from a number of sources, ranging from clinical pharmacology to …

It is known that despite large R&D resources and expenses, the conventional drug discovery
process has become increasingly time-consuming and elicits a relatively high attrition rate …

Systematic investigation of older approved drugs for newer therapeutic indications helps in
reducing the time and money required to bring a medicine to the market, by circumventing …

Drug repurposing is a widely used approach originally developed to aid in the identification
of new uses of already existing drugs outside the scope of the original medical indication [1] …

Repurposing marketed drugs or compounds in development for alternative indications is not
new in the pharmaceutical industry. It is in fact quite common but it has been mostly done by …

Repositioning or" repurposing" of existing therapies for indications of alternative disease is
an attractive approach that can generate lower costs and require a shorter approval time …

The wealth of knowledge and multi-omics data available in drug research has allowed the
rise of several computational methods in the drug discovery field, resulting in a novel and …